FDA Investigator Walter L Fava

Walter L Fava has conducted inspections on 41 sites in 1 countries as of 20 Jun 2006. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
41
Last Inspection Date:
20 Jun 2006
Investigator Role:
FDA Investigator
Redica ID:
100005065
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Walter L Fava:
Alice S Tsao, Alicia M Mozzachio, Alison N Stieg, Anita R Michael, Annet R Rajan, Anthony F Lorenzo, Anthony W Hite, Anthony W Lee, Ashley L Reiber, Austin B Appler, Barbara A Gullick, Bijoy Panicker, Brooke K Higgins, Brooke K Seeman, Bruce C Kovak, C Tyfrans Francis, Candice C Mandera, Candice J Cortes, Carol L Rehkopf, Carole L Jones, Catherine O Lamptey, Chaltu Nwakijra, Charles M Kerns, BLT DO, Cheryl L Watson, Chiang Syin, PhD, Christina K Theodorou, Chryste D Best, Clarice J Ahn, Clifton C Francis, Daniel R Azar, David A Oluwo, Denise R Beuttenmuller, Derek S Smith, PhD, Diane T Bargo, Diane T O'brien, Dianne H Milazzo, Donald L Lech, Douglas A Campbell, Dr. Dominick Roselle, Dr. Roslyn F Powers, Dr. Yubing Tang, Edette J Newby, Edmund F Mrak, Jr, Edward P Potter, Elizabeth A Laudig, Emest F Bizjak, Ephrem Hunde, PhD, Erin L Mcfiren, Esaw, Gale L Glinecki, George J Flynn, George Pyramides, Gerald B Seaborn, Jr, Heath R Harley, Hector Jcolon Torres, Hongna Wang, Jacqueline Johnson, Jaison J Eapen, James M Mason, James M Simpson, James W Leonette, Jamie D Richardson, Jamie D Swann, Janet A Rajan, Jean Blackston Hill, Jesse P Hardin, Jessica Hankins, PhD, John Dan, John M Gusto, Johnson, Jonah S Ufferfilge, Jonathan W Chapman, Jose R Hernandez, Joseph L Despins, PhD, Joseph W Matthews, Julie A Silberberg, Junho Pak, Justin A Hefferman, Karen A Briggs, Karen A Spencer, Kathleen M Jordan, Keith M Reilly, Kelly L Anderson, Kendra L Brooks, Kenneth M Gordon, Kenneth Nieves, Kenneth R Merritt, Ko U Min, Kristina L Conroy, La Tasham Gunter, Lauren N Barber, Laurissa S Flowers, Lawrence Harmon, Jr, LCDR Debra Emerson, LCDR Wilfred A Darang, Lori A Holmquist, Lori S Lawless, Lorraine L Chavis, LT Luis O Rodriguez, LT Melanie M Mayor, USPHS, Lynette P Salisbury, Malgorzata G Norton, PhD, Marcellinus D Dordunoo, Marcus A Ray, Margaret M Doherty, Marie A Fadden, Marion Michaelis, Marvin D Jones, Matthew M Henciak, Meghan Murphy, Melissa J Garcia, Merideth K Rose, Michael J Vardon, Michael O Idowu, Michael Shanks, MS, Mildred L Mccray, Monique Rac Lester, Nancy L Meade, Nebil A Oumer, Nicholas A Violand, Nicole K Trudel, Nina D Patel, Olaide Akinmade, Patricia A Morrow, Patrick C Klotzbuecher, Paul Mouris, Prabhu P Raju, Pratik S Upadhyay, DDC, Quyen T Tran, Rachael O Oyewole, Rachel C Harrington, Rebecca Rodriguez, Regina Gibson Melton, Rina Bhikha, Robert Durkin, Robert J Martin, Sarah M Shannon, Scott T Panagiotis, Seemay A Lee, Sena G Dissmeyer, Sharon K Thoma, PharmD, Sherry L Secrist, BLT DO, Shirshendu K Deb, PhD, Simone E Pitts, Stacey A Priest, Stanley M Shepperson, Stephanie L Shapley, Steven P Donald, Susan J Essenmacher, Suzanne M Healy, Suzanne M Muchene, Tamara N Champion, Tania E Garcia, Tania E Vizcaino, Teresa L Fox, Theresa M Smedley, Thomas N Adjabeng, Tiffani D Wilson, Tonia F Bernard, Toyin B Oladimeji, Vesna V Stanoyevitch, Viviana Matta, Vivin George, Vlada Matusovsky, Wanda Y Fields, Wanda Y Honeyblue, Wayne L Jefferson, Wendy R Blame, William A Warnick, William H Linkroum, Yvins Dezan, Yvonne C Mcknight, Zhongren Wu

Walter L Fava's Documents

Publish Date Document Type Title
June, 2003 EIR Cangene BioPharma, LLC - EIR, 2003-06-06
March, 2003 FDA 483 Warner Graham LLLP - Form 483, 2003-03-19
May, 2006 EIR Pharmaceutics International, Inc. - EIR, 2006-05-12
August, 2002 EIR Option Care Pharmacy - EIR, 2002-08-08
March, 2006 FDA 483 Cangene BioPharma, LLC - Form 483, 2006-03-31
February, 2006 FDA 483 Actavis Mid-Atlantic, LLC. - Form 483, 2006-02-17
October, 2003 EIR Central Admixture Pharmacy Services Inc - EIR, 2003-10-15
October, 2005 FDA 483 Central Admixture Pharmacy Services Inc - Form 483, 2005-10-12
February, 2004 FDA 483 Response Cangene BioPharma, LLC - Form 483R, 2004-02-03
February, 2004 EIR Cangene BioPharma, LLC - EIR, 2004-02-03
June, 2003 FDA 483 Cangene BioPharma, LLC - Form 483, 2003-06-06
October, 2002 EIR ZOETIS INC - EIR, 2002-10-17
May, 2006 EIR Pharmaceutics International, Inc. - EIR, 2007-06-26
August, 2002 FDA 483 Option Care Pharmacy - Form 483, 2002-08-08
May, 2006 FDA 483 Response Pharmaceutics International, Inc. - Form 483R, 2006-05-12
June, 2003 FDA 483 Response Cangene BioPharma, LLC - Form 483R, 2003-06-19
April, 2006 FDA 483 Rhodia, Inc. - Form 483, 2006-04-28
February, 2004 FDA 483 Cangene BioPharma, LLC - Form 483, 2004-02-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more